1. Home
  2. AYTU vs MFI Comparison

AYTU vs MFI Comparison

Compare AYTU & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • MFI
  • Stock Information
  • Founded
  • AYTU N/A
  • MFI 2002
  • Country
  • AYTU United States
  • MFI Hong Kong
  • Employees
  • AYTU N/A
  • MFI N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • MFI
  • Sector
  • AYTU Health Care
  • MFI
  • Exchange
  • AYTU Nasdaq
  • MFI NYSE
  • Market Cap
  • AYTU 8.3M
  • MFI 8.2M
  • IPO Year
  • AYTU N/A
  • MFI 2024
  • Fundamental
  • Price
  • AYTU $1.78
  • MFI $0.86
  • Analyst Decision
  • AYTU
  • MFI
  • Analyst Count
  • AYTU 0
  • MFI 0
  • Target Price
  • AYTU N/A
  • MFI N/A
  • AVG Volume (30 Days)
  • AYTU 3.7M
  • MFI 495.9K
  • Earning Date
  • AYTU 05-14-2025
  • MFI 06-10-2025
  • Dividend Yield
  • AYTU N/A
  • MFI N/A
  • EPS Growth
  • AYTU N/A
  • MFI N/A
  • EPS
  • AYTU N/A
  • MFI N/A
  • Revenue
  • AYTU $77,691,000.00
  • MFI $3,358,264.00
  • Revenue This Year
  • AYTU N/A
  • MFI N/A
  • Revenue Next Year
  • AYTU $8.14
  • MFI N/A
  • P/E Ratio
  • AYTU $6.70
  • MFI N/A
  • Revenue Growth
  • AYTU N/A
  • MFI N/A
  • 52 Week Low
  • AYTU $0.95
  • MFI $0.51
  • 52 Week High
  • AYTU $3.23
  • MFI $1.58
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 55.38
  • MFI N/A
  • Support Level
  • AYTU $1.90
  • MFI N/A
  • Resistance Level
  • AYTU $2.70
  • MFI N/A
  • Average True Range (ATR)
  • AYTU 0.20
  • MFI 0.00
  • MACD
  • AYTU -0.01
  • MFI 0.00
  • Stochastic Oscillator
  • AYTU 37.84
  • MFI 0.00

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via the internet or a platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

Share on Social Networks: